QQ客服 官方微博 反馈留言

	Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling
	Liu, Chenghai; Tao, Yanyan; Li, Shu; Wang, Qinglan
刊名	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
	2016
卷号	359期号:2
ISSN号	0022-3565
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3647511
专题	上海中医药大学
推荐引用方式 GB/T 7714	Liu, Chenghai,Tao, Yanyan,Li, Shu,et al. Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2016,359(2).
APA	Liu, Chenghai,Tao, Yanyan,Li, Shu,&Wang, Qinglan.(2016).Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,359(2).
MLA	Liu, Chenghai,et al."Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling".JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 359.2(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。